Moving beyond the current limits of data analysis in longevity and healthy lifespan studies

Drug Discov Today. 2019 Dec;24(12):2273-2285. doi: 10.1016/j.drudis.2019.08.008. Epub 2019 Sep 6.


Living longer with sustainable quality of life is becoming increasingly important in aging populations. Understanding associative biological mechanisms have proven daunting, because of multigenicity and population heterogeneity. Although Big Data and Artificial Intelligence (AI) could help, naïve adoption is ill advised. We hold the view that model organisms are better suited for big-data analytics but might lack relevance because they do not immediately reflect the human condition. Resolving this hurdle and bridging the human-model organism gap will require some finesse. This includes improving signal:noise ratios by appropriate contextualization of high-throughput data, establishing consistency across multiple high-throughput platforms, and adopting supporting technologies that provide useful in silico and in vivo validation strategies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / physiology
  • Animals
  • Artificial Intelligence
  • Big Data
  • Data Analysis
  • High-Throughput Screening Assays / methods*
  • Humans
  • Longevity / physiology*
  • Quality of Life*